NCT06189625 (PED_HUIL1223) is a NA clinical trial of Control in Mild Ankle Sprain, sponsored by Hospital Universitario Infanta Leonor.

Who is sponsoring NCT06189625?

NCT06189625 is sponsored by Hospital Universitario Infanta Leonor.

What drugs are being tested in NCT06189625?

Interventions in NCT06189625: Control, Functional bandage.

What condition does NCT06189625 study?

NCT06189625 studies Mild Ankle Sprain.

Is NCT06189625 still recruiting?

NCT06189625 is currently completed. Last updated 17 January 2024.

Last reviewed 2024-01-17 · How we verify

NCT06189625: PED_HUIL1223

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mild Ankle Sprain Treatment: Functional Bandaging vs. no Immobilization

Completed NA Last updated 17 January 2024

What this trial tests

NA trial testing Control in Mild Ankle Sprain in 113 participants. Completed in 18 May 2022.

Timeline

1 September 2021

Primary endpoint
18 May 2022

18 May 2022

Quick facts

Lead sponsor	Hospital Universitario Infanta Leonor
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	113
Start date	1 September 2021
Primary completion	18 May 2022
Estimated completion	18 May 2022
Sites	1 location across Spain

Drugs / interventions tested

Control
Functional bandage

Conditions studied

Mild Ankle Sprain — all drugs for Mild Ankle Sprain →

Sponsor

Hospital Universitario Infanta Leonor

Who can join

Adults 5 to 16, any sex, with Mild Ankle Sprain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ankle sprains represent a prevalent pathology among the pediatric population that can result in residual effects when treated incorrectly. However, there is a lack of scientific studies defining the most appropriate therapeutic approach. Our hypothesis is that patients treated solely with general measures, without external device support, experience a faster recovery compared to those treated with ankle immobilization. A clinical trial will be carried out by randomly assigning patients to either the functional bandaging group or the control group (general measures only). Prospective follow-up will be carried out by telephone, checking the functionality of the injured ankle using 'the Oxford Ankle Foot Questionnaire for Children (OxAFQ-C)', in addition to pain control and patient satisfaction with the treatment.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Non-restraint in pediatric ankle sprain: a non-inferiority randomized clinical trial.
Suarez-Cabezas S, Perez-Moneo B, Cabrerizo Ortiz M, Hortigüela Aparicio M, et al · · 2024 · PMID 39644340 · DOI 10.1007/s00431-024-05904-w
Non-restraint in pediatric ankle sprain: A non-inferiority randomized clinical trial.
Suarez-Cabezas S, Perez-Moneo B, Ortiz MC, Aparicio MH, et al · · 2024 · DOI 10.21203/rs.3.rs-4717190/v1

Verify or expand the search:

Other trials of Control

Trials testing the same drug.

NCT06064604 — Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke · NA · not yet recruiting
NCT04039386 — Psychosocial Interventions for Young Adults With Hip Pain · NA · not yet recruiting
NCT07042373 — Effects of Tobacco Abuse Liability-dependent Taxes in the ETM · NA · not yet recruiting
NCT07512999 — The Effect of Using Nature Sounds and Virtual Reality During the Non-Stress Test · NA · not yet recruiting
NCT07531563 — Protein Supplementation for Radiation- Induced Oral Mucositis in Head and Neck Cancer Patients Receiving Radiotherapy · NA · not yet recruiting

Other Hospital Universitario Infanta Leonor trials

Trials by the same sponsor.

NCT05293210 — Early Treatment Strategy With High-dose Dexamethasone in Patients With SARS-CoV-2 · Phase 3 · unknown
NCT05998499 — HIV-Infected Latin American Asylum Seekers in Europe: Insights From the EuroLatin HIV Cohort · completed
NCT04836780 — DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia · Phase 3 · unknown
NCT04730856 — Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 P · NA · completed
NCT04441385 — Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19). · Phase 2 · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06189625 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario Infanta Leonor
Last refreshed: 17 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06189625.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing